 |
|
 |
|
Daniel M. Halperin, MD, will be the featured guest for CCF's Luncheon with the Experts Facebook LIVE series on Thursday, February 25 from 12 noon to 1 pm, Eastern Time.
| |
Daniel M. Halperin, MD, is a medical oncologist and clinical investigator at MD Anderson Cancer Center in Texas, focusing on the development of novel treatments for patients with NETs in addition to providing clinical care to patients with NETs and other gastrointestinal cancers. He leads clinical trials of new drugs for patients with NETs at MD Anderson, and works with a team of laboratory and population scientists to understand more fully the molecular underpinnings and clinical manifestations of neuroendocrine tumors.
Dr. Halperin is also a member of the Neuroendocrine and Adrenal Tumor guideline committee of the National Comprehensive Cancer Network, contributing to evidence-based guidelines for the care of NET patients. Dr. Halperin has a particular interest in the immunology of neuroendocrine tumors and the use of immunotherapy for patients with NETs. As such, he has received peer-reviewed funding from the Neuroendocrine Tumor Research Foundation, as well as a Career Development Award from the American Society of Clinical Oncology, to understand the immunology of NETs and leads a clinical trial of immunotherapy with atezolizumab and bevacizumab for patients with specific rare solid tumors, including two separate cohorts of patients with advanced well-differentiated NETs.
| |
This Facebook LIVE event will be hosted by Rain Bennett, a longtime CCF filmmaker and dear friend of the NET community. To view the program come to CCF's Facebook page, https://www.facebook.com/Carcinoid/, at noon Eastern Time. There is no need to register and there is no special link.
Viewers are welcome to pose questions for Dr. Halperin during the live program.
| |
And for anyone not on Facebook, each of the presentations will be available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK SUBSCRIBE and HIT THE BELL to receive notifications each time a new video is uploaded.
With special thanks to TerSera Therapeutics, sponsor of the Luncheon with the Experts series.
| |
SAVE THE DATES
Luncheon with the Experts on Facebook LIVE
March 4, Herbert Chen, MD, FACS, surgical oncologist, is Chair of the Department of Surgery at University of Alabama at Birmingham (UAB), and the Surgeon-in-Chief of UAB Hospital and Health System. His clinical interests include endocrine surgery and he is a pioneer in radioguided parathyroid surgery. Dr. Chen’s lab has been continuously funded for over 20 years and studies the role of Notch signaling in thyroid and neuroendocrine cancers. He is the American Cancer Society MEN2 Thyroid Cancer Professor. Dr. Chen is the Editor-in-Chief of the American Journal of Surgery and serves on many other editorial boards.
March 11, Thorvardur (Thor) R. Halfdanarson, MD, is a medical oncologist and hematologist at the Mayo Clinic in Minnesota, focusing on gastrointestinal malignancies, especially neuroendocrine tumors and hepatobiliary tumors. His clinical focus includes: management of neuroendocrine malignancies of all types and origins; diagnosis and management of patients with cancers of unknown primary site; and thoracic malignancies, especially neuroendocrine tumors (lung NETs). In addition to his clinical activities, Dr. Halfdanarson is active in both research and education. His research focus is primarily on neuroendocrine tumors ranging from epidemiology to therapy including novel therapeutics in clinical trials.
March 18, Mark A. Lewis, MD, medical oncologist, is Director of Gastrointestinal Oncology at Intermountain Healthcare in Murray, Utah. His interests include young-onset cancers and hereditary cancer syndromes, shared decision-making, and patient-physician communication. Dr. Lewis is active in the SWOG Cancer Research Network, a clinical trials cooperative group created by the National Cancer Institute; within SWOG he chairs Adolescent & Young Adult (AYA) Oncology. He serves on the Communications Committee of NANETS, the North American Neuroendocrine Tumor Society, for which he is Past Chair and on the Board of Directors of the Neuroendocrine Tumor Research Foundation.
| |
|
|
|
The Carcinoid Cancer Foundation's educational, awareness and advocacy activities are made possible by your contributions. These crucial activities lead towards early detection, improving the quality of life for cancer survivors, and ultimately to a cure. The Carcinoid Cancer Foundation is a 501(c)(3) nonprofit organization. All contributions to The Carcinoid Cancer Foundation are tax-deductible to the extent allowed by law.
Thank you for your support!
|
 |
Carcinoid Cancer Foundation
118 North Bedford Road, Suite 100
Mount Kisco, NY 10549
Phone: 1-888-722-3132
E-Mail: carcinoid@carcinoid.org
|
|
|
|
